We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Novel Stress Biomarker Measurement Method Uses UV Range

By LabMedica International staff writers
Posted on 04 Jun 2019
Print article
Image: An instrument used for manufacturing test strips to measure stress biomarkers (Photo courtesy of Andrew Higley, University of Cincinnati).
Image: An instrument used for manufacturing test strips to measure stress biomarkers (Photo courtesy of Andrew Higley, University of Cincinnati).
A recent paper described a novel label-free method for quantitative detection of human performance “stress” biomarkers in different body fluids that is based on optical absorbance of biomarkers in the ultraviolet (UV) range of the spectrum.

The concentrations of stress biomarkers (hormones and neurotransmitters) in bodily fluids (blood, sweat, urine, and saliva) predict the physical and mental state of the individual. In the current study, investigators at the University of Cincinnati (OH, USA) focused on the stress biomarkers cortisol, serotonin, dopamine, norepinephrine, and neuropeptide Y.

The investigators characterized the UV properties of individual and multiple biomarkers in various biological fluids using a microfluidic/optoelectronic platform for biomarker detection in the 190-400 nm range.

For this study the prime focus was cortisol evaluation. The current limit of detection of cortisol in sweat is approximately 200 nanograms per milliliter, which is in the normal range. UV measurement revealed that plasma samples containing both serotonin and cortisol resulted in readily detectable absorption peaks at 203 (serotonin) and 247 (cortisol) nanometers, confirming the feasibility of simultaneous detection of multiple biomarkers in biological fluid samples. UV spectroscopy performed on various stress biomarkers showed a similar increasing absorption trend with concentration.

The investigators reported that the detection mechanism was label free, applicable to a variety of biomarker types, and able to detect multiple biomarkers simultaneously in various biofluids. A microfluidic flow cell was fabricated on a polymer substrate to enable point-of-care UV measurement of target biomarkers. The overall sensor combined sample dispensing and fluid transport to the detection location with optical absorption measurements with a UV light emitting diode (LED) and photodiode.

"I wanted something that is simple and easy to interpret," said senior author Dr. Andrew Steckl, professor of electrical engineering at the University of Cincinnati. "This may not give you all the information, but it tells you whether you need a professional who can take over. These stress biomarkers are found in all of these fluids, albeit in different quantities. It measures not just one biomarker but multiple biomarkers. And it can be applied to different bodily fluids. That is what is unique."

"You are not going to replace a full-panel laboratory blood test. That is not the intent," said Dr. Steckl. "But if you are able to do the test at home because you are not feeling well and want to know where you stand, this will tell whether your condition has changed a little or a lot."

The UV test for stress biomarkers was described in the May 24, 2019, issue of the journal American Chemical Society Sensors.

Related Links:
University of Cincinnati

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultra-Low Temperature Freezer
iUF118-GX
New
FOB+Transferrin+Calprotectin+Lactoferrin Test
CerTest FOB+Transferrin+Calprotectin+Lactoferrin Combo Test

Print article

Channels

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.